Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload

被引:50
作者
Falcao-Pires, Ines [1 ]
Palladini, Giuseppina [2 ]
Goncalves, Nadia [1 ]
van der Velden, Jolanda [3 ]
Moreira-Goncalves, Daniel [1 ]
Miranda-Silva, Daniela [1 ]
Salinaro, Francesco [2 ]
Paulus, Walter J. [3 ]
Niessen, Hans W. M. [4 ]
Perlini, Stefano [2 ]
Leite-Moreira, Adelino F. [1 ]
机构
[1] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, Cardiovasc R&D Unit, P-4200319 Oporto, Portugal
[2] Univ Pavia, Fdn IRCCS San Matteo, I-27100 Pavia, Italy
[3] Vrije Univ Med Ctr Amsterdam, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands
[4] Vrije Univ Med Ctr, Amsterdam, Netherlands
关键词
Diabetes mellitus; Diastolic function; Hypertrophy; Myocardial stiffness; Pressure-overload; Relaxation; BINDING PROTEIN-C; LIGHT-CHAIN PHOSPHORYLATION; HEART-FAILURE; CARDIAC-FUNCTION; MATRIX METALLOPROTEINASES; VENTRICULAR FUNCTION; FAILING HEART; END-PRODUCTS; RATS; HYPERTROPHY;
D O I
10.1007/s00395-011-0184-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic pressure-overload and diabetes mellitus are two frequent disorders affecting the heart. We aimed to characterize myocardial structural and functional changes induced by both conditions. Pressure-overload was established in Wistar-han male rats by supra-renal aortic banding. Six-weeks later, diabetes was induced by streptozotocin (65 mg/kg,ip), resulting in four groups: SHAM, banding (BA), diabetic (DM) and diabetic-banding (DB). Six-weeks later, pressure-volume loops were obtained and left ventricular samples were collected to evaluate alterations in insulin signalling pathways, extracellular matrix as well as myofilament function and phosphorylation. Pressure-overload increased cardiomyocyte diameter (BA 22.0 +/- A 0.4 mu m, SHAM 18.2 +/- A 0.3 mu m) and myofilament maximal force (BA 25.7 +/- A 3.6 kN/m(2), SHAM 18.6 +/- A 1.4 kN/m(2)), Ca2+ sensitivity (BA 5.56 +/- A 0.02, SHAM 5.50 +/- A 0.02) as well as MyBP-C, Akt and Erk phosphorylation, while decreasing rate of force redevelopment (K (tr); BA 14.9 +/- A 1.1 s(-1), SHAM 25.2 +/- A 1.5 s(-1)). At the extracellular matrix level, fibrosis (BA 10.8 +/- A 0.9%, SHAM 5.3 +/- A 0.6%), pro-MMP-2 and MMP-9 activities increased and, in vivo, relaxation was impaired (tau; BA 14.0 +/- A 0.9 ms, SHAM 12.9 +/- A 0.4 ms). Diabetes increased cardiomyocyte diameter, fibrosis (DM 21.4 +/- A 0.4 mu m, 13.9 +/- A 1.8%, DB 20.6 +/- A 0.4 mu m, 13.8 +/- A 0.8%, respectively), myofilament Ca(2+)sensitivity (DM 5.57 +/- A 0.02, DB 5.57 +/- A 0.01), advanced glycation end-product deposition (DM 4.9 +/- A 0.6 score/mm(2), DB 5.1 +/- A 0.4 score/mm(2), SHAM 2.1 +/- A 0.3 score/mm(2)), and apoptosis, while decreasing K (tr) (DM 13.5 +/- A 1.9 s(-1), DB 15.2 +/- A 1.4 s(-1)), Akt phosphorylation and MMP-9/TIMP-1 and MMP-1/TIMP-1 ratios. Diabetic hearts were stiffer (higher end-diastolic-pressure: DM 7.0 +/- A 1.2 mmHg, DB 6.7 +/- A 0.7 mmHg, SHAM 5.3 +/- A 0.4 mmHg, steeper end-diastolic-pressure-volume relation: DM 0.59 +/- A 0.18, DB 0.83 +/- A 0.17, SHAM 0.41 +/- A 0.10), and hypo-contractile (decreased end-systolic-pressure-volume-relation). DB animals presented further pulmonary congestion (Lungs/body-weight: DB 5.23 +/- A 0.21 g/kg, SHAM 3.80 +/- A 0.14 g/kg) as this group combined overload-induced relaxation abnormalities and diabetes-induced stiffness. Diabetes mellitus and pressure overload led to distinct diastolic dysfunction phenotypes: while diabetes promoted myocardial stiffening, pressure overload impaired relaxation. The association of these damages accelerates the progression of diastolic heart failure progression in diabetic-banded animals.
引用
收藏
页码:801 / 814
页数:14
相关论文
共 52 条
[1]   EFFECTS OF HYPERTENSION AND CORONARY CONSTRICTION ON CARDIAC-FUNCTION, MORPHOLOGY, AND CONTRACTILE PROTEINS IN RATS [J].
ANVERSA, P ;
LI, P ;
MALHOTRA, A ;
ZHANG, X ;
HERMAN, MV ;
CAPASSO, JM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (02) :H713-H724
[2]   Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes [J].
Aronson, D .
JOURNAL OF HYPERTENSION, 2003, 21 (01) :3-12
[3]   Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes [J].
Berg, TJ ;
Snorgaard, O ;
Faber, J ;
Torjesen, PA ;
Hildebrandt, P ;
Mehlsen, J ;
Hanssen, KF .
DIABETES CARE, 1999, 22 (07) :1186-1190
[4]   Cardiomyocyte stiffness in Diastolic heart failure [J].
Borbély, A ;
van der Velden, J ;
Papp, Z ;
Bronzwaer, JGF ;
Edes, I ;
Stienen, GJM ;
Paulus, WJ .
CIRCULATION, 2005, 111 (06) :774-781
[5]  
Brown RA, 1996, BASIC RES CARDIOL, V91, P353
[6]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[7]   LEFT-VENTRICULAR FAILURE INDUCED BY LONG-TERM HYPERTENSION IN RATS [J].
CAPASSO, JM ;
PALACKAL, T ;
OLIVETTI, G ;
ANVERSA, P .
CIRCULATION RESEARCH, 1990, 66 (05) :1400-1412
[8]   Insulin signaling pathways and cardiac growth [J].
DeBosch, Brian J. ;
Muslin, Anthony J. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (05) :855-864
[9]   Subcellular remodeling and heart dysfunction in chronic diabetes [J].
Dhalla, NS ;
Liu, XL ;
Panagia, V ;
Takeda, N .
CARDIOVASCULAR RESEARCH, 1998, 40 (02) :239-247
[10]   RISK-FACTORS FOR CARDIOVASCULAR-DISEASE IN IDDM - A STUDY OF IDENTICAL-TWINS [J].
DUBREY, SW ;
REAVELEY, DR ;
SEED, M ;
LANE, DA ;
IRELAND, H ;
ODONNELL, M ;
OCONNOR, B ;
NOBLE, MI ;
LESLIE, RDG .
DIABETES, 1994, 43 (06) :831-835